Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...
The gross proceeds to the Company from the offering are expected to be approximately $4.3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...
Vivos Therapeutics shares rose on Wednesday after the company said its oral medical device for pediatric sleepapnea and snoring received 510(k) clearance from the Food and Drug Administration.
Vivos is poised to disrupt the very significant pediatric obstructive sleepapnea (OSA) market with new FDA clearance and new strategic marketing and distribution model Vivos' DNA appliance ...
Your doctor may recommend a sleep apnea test if they suspect you have it. You can test for sleepapnea at home or in-lab, depending on your preferences and your doctor’s suggestions. You’ll ...
Results that may be inaccessible to you are currently showing.